Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
Classifica tra le azioni #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
Prezzo delle azioni
$0.00695
Ultima sincronizzazione: 2024-10-29
Capitalizzazione di mercato
$536.40
Variazione (1 giorno)
-0.71%
Variazione (1 anno)
0.00%
Paese
US
Scambia BIOLASE, Inc. (BIOL)

Categoria

Margine operativo per BIOLASE, Inc. (BIOL)
Margine operativo al August 2026 TTM: -36.48%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di BIOLASE, Inc., il margine operativo attuale (TTM) è -36.48%. Alla fine del 2022, il margine operativo era -52.28%.
Storico del margine operativo per BIOLASE, Inc. da 2000 a 2026
Margine operativo alla fine di ogni anno
Anno Margine Operativo Cambia
2026 (TTM) -36.48% 0.00%
2023 -36.48% -30.22%
2022 -52.28% 27.14%
2021 -41.12% -49.47%
2020 -81.37% 96.88%
2019 -41.33% -8.66%
2018 -45.25% 17.72%
2017 -38.44% 33.10%
2016 -28.88% -29.70%
2015 -41.08% 9.11%
2014 -37.65% 93.18%
2013 -19.49% 341.95%
2012 -4.41% -46.22%
2011 -8.20% -81.29%
2010 -43.83% 541.73%
2009 -6.83% -49.74%
2008 -13.59% 1.34%
2007 -13.41% 93.23%
2006 -6.94% -74.67%
2005 -27.40% 77.58%
2004 -15.43% -201.78%
2003 15.16% 78.35%
2002 8.50% -518.72%
2001 -2.03% -94.60%
2000 -37.62% 0.00%
Margine operativo per aziende simili o concorrenti
Azienda Margine Operativo Differenza del margine operativo Il paese
17.03% -100.47%
US
22.03% -100.60%
US
17.86% -100.49%
IE
21.46% -100.59%
US
28.09% -100.77%
US
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.